Prognostic significance of the hemoglobin A1c level in non-diabetic patients undergoing percutaneous coronary intervention: a meta-analysis.

CONCLUSIONS: An abnormal HbA1c level is an independent risk factor for long-term adverse clinical events in non-diabetic patients with CAD after PCI. Strict control of HbA1c levels may improve patient survival. Further studies in different countries and prospective cohort studies with a large sample size are required to verify the association.
PMID: 32826614 [PubMed - as supplied by publisher]

Source: Chinese Medical Journal - August 17, 2020 Category: General Medicine Authors: Li Y, Li XW, Zhang YH, Zhang LM, Wu QQ, Bai ZR, Si J, Zuo XB, Shi N, Li J, Chu X Tags: Chin Med J (Engl) Source Type: research